Share this post on:

Product Name :
Delafloxacin

Search keywords :
Delafloxacin

drugId :
null

Target Vo:
Topoisomerase IV

Target Vo Short Name :
Topoisomerase IV

Moa_Name:
Bacterial DNA gyrase inhibitors

First Approval Country :
United States

First Approval Date Filter:
2017

Origin Company_Name :
Wakunaga Pharmaceutical Co Ltd

Active Company_Name :
A. Menarini Industrie Farmaceutiche Riunite Srl

Active Indication_Name:
Community Acquired Pneumonia

In Active Indication_Name:
Pneumonia

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:
NDA/BLA

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
ICAM1 Mouse mAb Epigenetic Reader Domain
Adecatumumab In Vivo
CD34 Antibody: CD34 Antibody is an unconjugated, approximately 39 kDa, rabbit-derived, anti-CD34 polyclonal antibody. CD34 Antibody can be used for: WB, ELISA, IHC-P, IHC-F, Flow-Cyt, IF expriments in human, mouse, and predicted: rat, dog, pig, cow, rabbit background without labeling.

Share this post on:

Author: Interleukin Related